z-logo
open-access-imgOpen Access
Antithrombotic effects of a platelet fibrinogen receptor antagonist in a canine model of carotid artery thrombosis.
Author(s) -
Robert N. Willette,
Charles F. Sauermelch,
R Rycyna,
Sandip Sarkar,
G Feuerstein,
Andrew J. Nichols,
Eliot H. Ohlstein
Publication year - 1992
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.23.5.703
Subject(s) - medicine , thrombosis , cardiology , aspirin , platelet , common carotid artery , anesthesia , ex vivo , thrombus , in vivo , carotid arteries , microbiology and biotechnology , biology
Platelet-fibrin thrombi in the lumen of atherostenotic carotid arteries may underlie transient ischemic attacks and cerebral infarction. For this reason, we investigated the antiplatelet and antithrombotic effects of a novel and potent platelet fibrinogen receptor (glycoprotein IIb/IIIa) antagonist (SK&F 106760).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom